|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Gain-of-Function Mutation of Card14 Leads to Spontaneous Psoriasis-like Skin Inflammation through Enhanced Keratinocyte Response to IL-17A.
|
29980436 |
2018 |
|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
|
29689250 |
2018 |
|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
Biomarker
|
disease |
MGD |
CARD14 Gain-of-Function Mutation Alone Is Sufficient to Drive IL-23/IL-17-Mediated Psoriasiform Skin Inflammation In Vivo.
|
29689250 |
2018 |
|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
The paracaspase MALT1 mediates CARD14-induced signaling in keratinocytes.
|
27113748 |
2016 |
|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
Psoriasis mutations disrupt CARD14 autoinhibition promoting BCL10-MALT1-dependent NF-κB activation.
|
27071417 |
2016 |
|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
CARD14 alterations in Tunisian patients with psoriasis and further characterization in European cohorts.
|
26358359 |
2016 |
|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
GeneticVariation
|
disease |
BEFREE |
SNP rs11652075 in the CARD14 gene as a risk factor for psoriasis (PSORS2) in a Spanish cohort.
|
23905699 |
2013 |
|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasis.
|
22521419 |
2012 |
|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
GeneticVariation
|
disease |
UNIPROT |
PSORS2 is due to mutations in CARD14.
|
22521418 |
2012 |
|
| Entrez Id: |
79092 |
| Gene Symbol: |
CARD14 |
CARD14
|
0.810 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
|
| Entrez Id: |
6607 |
| Gene Symbol: |
SMN2 |
SMN2
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the IMDs group, 22 (27.2%) showed ANA positivity (titers ≥1:160), 3 (3.7%) SMA positivity (titers ≥1:160), 24 (29.6%) had cryoglobulinemia, 25 (30.9%) autoimmune thyroiditis, 4 (4.9%) psoriasis, 2 (2.5%) B-cell non-Hodgkin lymphoma and 1 (1.2%) autoimmune hemolytic anemia.
|
27476469 |
2016 |
|
| Entrez Id: |
10950 |
| Gene Symbol: |
BTG3 |
BTG3
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
In the IMDs group, 22 (27.2%) showed ANA positivity (titers ≥1:160), 3 (3.7%) SMA positivity (titers ≥1:160), 24 (29.6%) had cryoglobulinemia, 25 (30.9%) autoimmune thyroiditis, 4 (4.9%) psoriasis, 2 (2.5%) B-cell non-Hodgkin lymphoma and 1 (1.2%) autoimmune hemolytic anemia.
|
27476469 |
2016 |
|
| Entrez Id: |
6606 |
| Gene Symbol: |
SMN1 |
SMN1
|
0.010 |
Biomarker
|
disease |
BEFREE |
In the IMDs group, 22 (27.2%) showed ANA positivity (titers ≥1:160), 3 (3.7%) SMA positivity (titers ≥1:160), 24 (29.6%) had cryoglobulinemia, 25 (30.9%) autoimmune thyroiditis, 4 (4.9%) psoriasis, 2 (2.5%) B-cell non-Hodgkin lymphoma and 1 (1.2%) autoimmune hemolytic anemia.
|
27476469 |
2016 |